Compared to the control cells, the protein half‐life of endogenous AXL was dramatically decreased and the ubiquitination of AXL was significantly increased in shSTAMBPL1 treated primary cancer cells (Figure S7E,F, Supporting Information). This evidence concerns the gene AXL and cancer.